Catherine Hu

Catherine Hu is a senior executive at ElevateBio, where she serves as the Senior Vice President of Corporate Affairs and Investor Relations, as well as Chief of Staff.12 Here are some key details about her background and role:

Professional Experience

Catherine joined ElevateBio in 2021 to lead the company's investor relations and corporate affairs functions.1 In her current role, she is responsible for managing the company's relationships with investors and overseeing corporate communications.

Career History

Prior to joining ElevateBio, Catherine held similar positions at other biotechnology companies:

• She led investor relations, corporate affairs, and patient advocacy functions at Scholar Rock, Inc.1
• She was part of the investor relations team at Alexion Pharmaceuticals1

Catherine has extensive experience in the financial sector as well. She spent over a decade as an equity research analyst covering biopharmaceuticals and medical devices at various investment banks, including:

• Bank of America
• Barclays
• Credit Suisse
• Deutsche Bank1

Education

Catherine received her B.S. from New York University's Leonard N. Stern School of Business.14

Impact at ElevateBio

In her role at ElevateBio, Catherine has been instrumental in shaping the company's communications strategy and raising awareness of its innovative approach to cell and gene therapy development. She has worked closely with the company's leadership to articulate ElevateBio's value proposition and vision for the future of precision medicine.3

Catherine's LinkedIn profile can be found under the username catherine-hu-b871527, as mentioned in the query.4